Analyst firms · BTIG · OBIO
BTIG OBIO price target and rating history
Orchestra BioMed Holdings Inc. (OBIO) · Health Care
BTIG rates Orchestra BioMed Holdings Inc. (OBIO) Buy with a $10 price target, as of its latest action on Sep 10, 2026. It has published 3 rating actions on OBIO since March 2025, including 1 upgrade and 1 downgrade.
- Current rating
- Buy
- Price target
- $10
- Median target, all firms
- Too few
- Actions on OBIO
- 3
BTIG price target on OBIO
Every BTIG rating on OBIO
- Sep 10, 2026
- Aug 20, 2025DowngradeBTIG downgrades to Neutral from Buy
- Mar 20, 2025
How other firms rate OBIO
Each firm's latest rating and stated target in the last 12 months.
Questions about BTIG and OBIO
- What is BTIG's price target for OBIO?
- BTIG's latest stated price target for Orchestra BioMed Holdings Inc. (OBIO) is $10, from its action on Sep 10, 2026.
- What is BTIG's rating on OBIO?
- BTIG rates OBIO Buy, a bullish rating, as of Sep 10, 2026.
- When did BTIG last change its view on OBIO?
- On Sep 10, 2026, BTIG upgrades to Buy from Neutral, price target $10.
All BTIG ratingsOBIO news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.